Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients, Cancer, vol.83, pp.1128-1135, 1998. ,
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway, Nat Genet, vol.47, pp.1194-1199, 2015. ,
Pembrolizumab versus Ipilimumab in advanced melanoma, N Engl J Med, vol.372, pp.2521-2532, 2015. ,
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden, Genome Med, vol.9, issue.1, p.34, 2017. ,
High response rate to PD-1 blockade in desmoplastic melanomas, Nature, vol.553, issue.7688, pp.347-350, 2018. ,
,